Table 2.
Characteristic | BHADP score vs PHQ-8 score | BHADP score vs FSMC score | BHADP score vs EQ-5D-5L score | BHADP score vs GSE score | ||||||||
|
β coefficient (95% CI) | P value | β coefficient (95% CI) | P value | β coefficient (95% CI) | P value | β coefficient (95% CI) | P value | ||||
Intercept | 29 (19 to 39) | <.001 | 26 (13 to 39) | <.001 | 54 (43 to 65) | <.001 | 50 (38 to 62) | <.001 | ||||
Age | −0.07 (−0.25 to 11) | .40 | −0.01 (−0.22 to 0.19) | .90 | −0.02 (−0.20 to 0.16) | .80 | −0.01 (−0.20 to 0.19) | .93 | ||||
Sex | ||||||||||||
|
Female | —a | N/Ab | — | N/A | — | N/A | — | N/A | |||
|
Male | 0.96 (−2.2 to 4.1) | .50 | 1.7 (−1.8 to 5.2) | .30 | 1.3 (−1.7 to 4.3) | .40 | 2.2 (−1.1 to 5.5) | .20 | |||
BMI | −0.13 (−0.39 to 0.13) | .30 | −0.23 (−0.52 to 0.06) | .11 | −0.34 (−0.59 to −0.09) | .008 | −0.16 (−0.45 to 0.12) | .20 | ||||
MSc duration | −0.12 (−0.28 to 0.04) | .14 | −0.12 (−0.30 to 0.07) | .20 | −0.15 (−0.31 to 0.01) | .06 | −0.13 (−0.31 to 0.05) | .15 | ||||
EDSSd score | 0.52 (−0.65 to 1.7) | .40 | 0.18 (−1.1 to 1.5) | .80 | −0.95 (−2.1 to 0.23) | .11 | −0.18 (−1.4 to 1.1) | .80 | ||||
PHQ-8 score | 0.90 (0.56 to 1.2) | <.001 | N/A | N/A | N/A | N/A | N/A | N/A | ||||
FSMC score | N/A | N/A | 0.16 (0.07 to 0.25) | <.001 | N/A | N/A | N/A | N/A | ||||
EQ-5D-5L score | N/A | N/A | N/A | N/A | −17 (−23 to −11) | <.001 | N/A | N/A | ||||
GSE score | N/A | N/A | N/A | N/A | N/A | N/A | −0.49 (−0.72 to −0.25) | <.001 |
aReference category.
bN/A: not applicable.
cMS: multiple sclerosis.
dEDSS: Expanded Disability Status Scale.